©2025 Unlimited Sciences. All rights reserved.
We hate pop-ups as much as you do, but if you want to stay up to date about the latest news in the psychedelic space and learn about our ground-breaking psychedelic research, please consider signing up for our newsletter below.
On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression
Abstract
Results from a recent Phase II trial of psilocybin-assisted therapy for treatment-resistant depression suggest modest efficacy but raise concerns about potential for serious adverse effects. The study highlights the need for rigorous assessment of blinding integrity, expectancy, and further study of factors that may contribute to risk in vulnerable populations.
Stay Updated On Psychedelic News
Join our newsletter to receive updates about the latest psychedelic news, hear about our ground-breaking research, and learn what we think about the latest trends shaping the future of psychedelics.
Planning Your Psychedelic Trip?
Our Info Line Can Help.
We provide 100% free, 1:1 guidance for anyone preparing for a psychedelic experience. Learn more about our evidence-based approach or book a call today.
Learn MoreBook a CallAbout:
Conditions:
Research Keywords:
Return to the Research Library >